Outcome after thrombolysis for acute isolated posterior cerebral artery occlusion.
Standard
Outcome after thrombolysis for acute isolated posterior cerebral artery occlusion. / Meier, Niklaus; Fischer, Urs; Schroth, Gerhard; Findling, Oliver; Brekenfeld, Caspar; El-Koussy, Marwan; Marchis, De; Marco, Gian; Mono, Marie-Luise; Jung, Simon; Gralla, Jan; Nedeltchev, Krassen; Mattle, Heinrich P; Arnold, Marcel.
in: CEREBROVASC DIS, Jahrgang 32, Nr. 1, 1, 2011, S. 79-88.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Outcome after thrombolysis for acute isolated posterior cerebral artery occlusion.
AU - Meier, Niklaus
AU - Fischer, Urs
AU - Schroth, Gerhard
AU - Findling, Oliver
AU - Brekenfeld, Caspar
AU - El-Koussy, Marwan
AU - Marchis, De
AU - Marco, Gian
AU - Mono, Marie-Luise
AU - Jung, Simon
AU - Gralla, Jan
AU - Nedeltchev, Krassen
AU - Mattle, Heinrich P
AU - Arnold, Marcel
PY - 2011
Y1 - 2011
N2 - To date, there is limited data on intra-arterial thrombolysis (IAT) and intravenous thrombolysis (IVT) for isolated posterior cerebral artery (PCA) occlusion. We aimed to evaluate recanalization, outcome and quality of life in patients who undergo thrombolysis for isolated PCA occlusion.
AB - To date, there is limited data on intra-arterial thrombolysis (IAT) and intravenous thrombolysis (IVT) for isolated posterior cerebral artery (PCA) occlusion. We aimed to evaluate recanalization, outcome and quality of life in patients who undergo thrombolysis for isolated PCA occlusion.
KW - Humans
KW - Male
KW - Aged
KW - Female
KW - Quality of Life
KW - Treatment Outcome
KW - Feasibility Studies
KW - Injections, Intra-Arterial
KW - Fibrinolytic Agents/administration & dosage/therapeutic use
KW - Tissue Plasminogen Activator/administration & dosage/therapeutic use
KW - Arterial Occlusive Diseases/drug therapy
KW - Injections, Intravenous
KW - Posterior Cerebral Artery
KW - Thrombolytic Therapy/adverse effects/methods
KW - Humans
KW - Male
KW - Aged
KW - Female
KW - Quality of Life
KW - Treatment Outcome
KW - Feasibility Studies
KW - Injections, Intra-Arterial
KW - Fibrinolytic Agents/administration & dosage/therapeutic use
KW - Tissue Plasminogen Activator/administration & dosage/therapeutic use
KW - Arterial Occlusive Diseases/drug therapy
KW - Injections, Intravenous
KW - Posterior Cerebral Artery
KW - Thrombolytic Therapy/adverse effects/methods
M3 - SCORING: Journal article
VL - 32
SP - 79
EP - 88
JO - CEREBROVASC DIS
JF - CEREBROVASC DIS
SN - 1015-9770
IS - 1
M1 - 1
ER -